Secondly, heightened public awareness of CML, coupled with the effective dissemination of preventative measures, such as genetic testing (e.g., COL6 A1-3, LAMA2 gene screening) and antenatal counseling, has contributed to the stabilization of CML prevalence following a transient period of growth [48–50]. This evidence concerns the gene LAMA2 and chronic myelogenous leukemia, BCR-ABL1 positive.